Cigarette Smoking and Components of the Metabolic Syndrome in the Indigenous Population of the Arctic Territory of Yakutia

Sargylana I. Sofronova, Maria P. Kirillina, Vyacheslav M. Nikolaev, Irina V. Kononova, Anna N. Romanova

International Journal of Biomedicine. 2020;10(4):467-471.
DOI: 10.21103/Article10(4)_OA26
Originally published December 10, 2020


The aim of this research was to study the influence of smoking on components of the metabolic syndrome and their relationship in the indigenous population of the Arctic territory of Yakutia.
Methods and Results: The material for the study was collected under expeditionary conditions in the Arctic territory of Yakutia in places of compact residence of indigenous peoples. Using the continuous method, we examined 348 subjects (225 women and 123 men). The average age of the respondents was 48.16±0.52 years (49.71±0.63 years for women and 44.98±0.91 years for men). The research program included the following sections: a questionnaire for objective assessment of state; anthropometric examination; assessment of blood pressure (BP);  determination of insulin and fasting glucose. In the survey, only those who smoked at least 1 cigarette per day during the last 12 months were considered smokers. The obtained results indicate that the indigenous population of the northern territory of Yakutia has a high frequency of risk factors for the development of cardiovascular pathology, such as overweight, obesity, and smoking. Overweight is equally common in both men and women; obesity is almost 2.5 times more common in women. An increase in body weight and systolic BP is not associated with smoking; however, the simultaneous combination of all these factors can affect the risk of cardiovascular incidents. A negative relationship between BMI and smoking was found. An increased index of insulin resistance is associated with the simultaneous spread of obesity among nonsmokers. The same association of glucose level with BP was obtained in both smokers and nonsmokers.
Conclusion: Metabolic disorders in the indigenous population of the northern territory of Yakutia are caused by a change in the traditional way of life and nutrition, with a decrease in physical activity and a lack of adherence to a healthy lifestyle.

smoking • overweight • obesity • insulin • glucose • blood pressure
  1. Gutiérrez-Fisac JL, Guallar-Castillón P, León-Muñoz LM, Graciani A, Banegas JR, Rodríguez-Artalejo F. Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study. Obes Rev. 2012 Apr;13(4):388-92. doi: 10.1111/j.1467-789X.2011.00964.x. 
  2. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012 Jan;70(1):3-21. doi: 10.1111/j.1753-4887.2011.00456.x. 
  3. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN, McIntire RK, Gutierrez HR, Cowan M, Paciorek CJ, Farzadfar F, Riley L, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012 Nov 20;10(1):22. doi: 10.1186/1478-7954-10-22. 
  4. Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 2015 Apr;26(4):193-200. doi: 10.1016/j.tem.2015.01.006. 
  5. Beverly JK, Budoff MJ. Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J Diabetes. 2020 Feb;12(2):102-104. doi: 10.1111/1753-0407.12970. 
  6. Bloomgarden ZT. Insulin resistance, dyslipidemia, and cardiovascular disease. Diabetes Care. 2007 Aug;30(8):2164-70. doi: 10.2337/dc07-zb08. 
  7. Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care. 2009 Feb;32(2):361-6. doi: 10.2337/dc08-0854. 
  8. Laakso M, Kuusisto J, Stančáková A, Kuulasmaa T, Pajukanta P, Lusis AJ, Collins FS, Mohlke KL, Boehnke M. The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases. J Lipid Res. 2017 Mar;58(3):481-493. doi: 10.1194/jlr.O072629. 
  9. Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1754-9. doi: 10.1161/ATVBAHA.111.241885. 
  10. Hirai FE, Moss SE, Klein BE, Klein R. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care. 2008 Mar;31(3):493-7. doi: 10.2337/dc07-1161.
  11. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998 Jan 14;279(2):119-24. doi: 10.1001/jama.279.2.119. 
  12. Pujades-Rodriguez M, George J, Shah AD, Rapsomaniki E, Denaxas S, West R, Smeeth L, Timmis A, Hemingway H. Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction. Int J Epidemiol. 2015 Feb;44(1):129-41. doi: 10.1093/ije/dyu218.
  13. WHO Report on the Global Tobacco Epidemic; 2013. Available at
  14. WHO global report on trends in prevalence of tobacco smoking 2000-2025 - Second edition. Available at:
  15. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011 Jul;90(1):164-8. doi: 10.1038/clpt.2011.105. 
  16. Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun 17;362(24):2295-303. doi: 10.1056/NEJMra0809890. 
  17. Pan A, Wang Y, Talaei M, Hu FB. Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review. Circulation. 2015 Nov 10;132(19):1795-804. doi: 10.1161/CIRCULATIONAHA.115.017926. 
  18. Li Y, Zhang T, Han T, Li S, Bazzano L, He J, Chen W. Impact of cigarette smoking on the relationship between body mass index and insulin: Longitudinal observation from the Bogalusa Heart Study. Diabetes Obes Metab. 2018 Jul;20(7):1578-1584. doi: 10.1111/dom.13259. 
  19. Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Watanabe S. Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. J Diabetes Investig. 2013 May 6;4(3):274-80. doi: 10.1111/jdi.12019. 
  20. Sofronova SI, Romanova AN, Kirillina MP, Nikolaev VM. [Ethnicity-dependent evaluation of excessive body mass and obesity in the native population of northern Yakutia]. Yakut Medical Journal. 2019;(2):76-78. doi: 10.25789/YMJ.2019.66.23. [Article in Russian].
  21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412-9. doi: 10.1007/BF00280883. 
  22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004 Jun;27(6):1487-95. doi: 10.2337/diacare.27.6.1487. 
  23. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. 
  24. Dolgalev IV, Brazovskaya NG, Ivanova AYu, Shipkhineeva AYu, Bogaychuk PM. [Influence of arterial hypertension, smoking, and their combination on mortality (according to the results of a 27-year cohort prospective study of the unorganized population of Tomsk)]. Russian Journal of Cardiology. 2019;(1):32-37. doi: 10.15829/1560-4071-2019-1-32-37. [Article in Russian].
  25. Maksimov SA, Skripchenko AE, Indukaeva EV, Mulerova TA, Danilchenko YV, Tabakaev MV, Artamonova GV. [Relationships between smoking, coronary artery disease and cardiovascular risk factors (ESSE-RF in the Kemerovo region)]. Complex Issues of Cardiovascular Diseases. 2017;6(4):21-26. doi: 10.17802/2306-1278-2017-6-4-21-26. [Article in Russian].
  26. Leone A. Smoking and hypertension: independent or additive effects to determining vascular damage? Curr Vasc Pharmacol. 2011 Sep;9(5):585-93. doi: 10.2174/157016111796642706.
  27. Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, Gong H, Hui C, Xu G, Li Y, Pan L, Zhang B, Shan G. The association between smoking and blood pressure in men: a cross-sectional study. BMC Public Health. 2017 Oct 10;17(1):797. doi: 10.1186/s12889-017-4802-x.
  28. Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, Ockene JK, Prentice RL, Speizer FE, Thun MJ, Jacobs EJ. Smoking and mortality--beyond established causes. N Engl J Med. 2015 Feb 12;372(7):631-40. doi: 10.1056/NEJMsa1407211. 
  29. Pannier B, Thomas F, Hanon O, Czernichow S, Lemogne C, Simon T, Simon JM, Danchin N. Individual 6-year systolic blood pressure change and impact on cardiovascular mortality in a French general population. J Hum Hypertens. 2016 Jan;30(1):18-23. doi: 10.1038/jhh.2015.44. 
  30. Pan A, Wang Y, Talaei M, Hu FB. Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review. Circulation. 2015 Nov 10;132(19):1795-804. doi: 10.1161/CIRCULATIONAHA.115.017926. 
  31. Purohit P, Mathur R. Hypertension association with serum lipoproteins, insulin, insulin resistance and C-Peptide: unexplored forte of cardiovascular risk in hypothyroidism. N Am J Med Sci. 2013 Mar;5(3):195-201. doi: 10.4103/1947-2714.109187. 

Download Article
Received October 30, 2020.
Accepted December 2, 2020.
©2020 International Medical Research and Development Corporation.